BioTech Medics has received preliminary independent clinical testing of its patented shban hand sanitizer solution to demonstrate that it kills the H1N1 (Swine) Influenza A virus. Preliminary lab
PTC Therapeutics (PTC) has entered into an exclusive research collaboration and licensing agreement with Roche for the development of orally bioavailable small molecules utilizing PTC’s technology called Gene
Unilife Australia has entered into a Merger Implementation Agreement with Unilife Corporation (Unilife US), a wholly owned subsidiary of Unilife Australia. The purpose of the Merger Implementation Agreement
Bayer CropScience has successfully ended a patent infringement dispute in China with the two Chinese companies Jiangsu Tian Rong Group (Tian Rong) and Yixing Hua Dong Agrochemical (Hua
Asahi Kasei has completed construction of a new integrated research complex within its plant and laboratory grounds in Fuji City, Shizuoka, with operation starting today as the Asahi
Ranbaxy Laboratories, has received orders from the national government to supply the generic version of Roche’s anti-viral Tamiflu, used to treat the H1N1 flu. Ranbaxy will supply 900,000
Bristol-Myers Squibb has completed its previously announced $2.4 billion acquisition of Medarex. As a result of the transaction, Medarex has become a wholly-owned subsidiary of Bristol-Myers Squibb. Bristol-Myers
Daiichi Sankyo and Ranbaxy have announced that Terapia, a subsidiary of Ranbaxy in Romania, will market the osteoporosis medication, Evista in Romania. Takashi Shoda, president and CEO of
Vitro Diagnostics, announced advances in its adult stem cell products and technology with application to cell-based therapy of cancer. Vitro’s proprietary stem cell technology and products, now subject
Sagent Pharmaceuticals has announced the launch of adenosine injection, an antiarrhythmic drug used to treat paroxysmal supraventricular tachycardia. Sagent will offer this latex-free, preservative-free adenosine product in 6mg
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.